We are live on
!
Find out more
RC
Rangeley Capital Portfolio holdings
AUM
$103M
1-Year Est. Return
77.32%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$111M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow
% of AUM
100.56%
Top 10 Holdings %
Top 10 Hldgs %
51%
Holding
82
New
82
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calumet Specialty Products
CLMT
|
+$11.2M |
| 2 |
Amplify Energy
AMPY
|
+$8.89M |
| 3 |
Burford Capital
BUR
|
+$6.19M |
| 4 |
Delek US
DK
|
+$5.98M |
| 5 |
Arbutus Biopharma
ABUS
|
+$5.37M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.99% |
| 2 | Healthcare | 13.1% |
| 3 | Materials | 12.21% |
| 4 | Real Estate | 10.73% |
| 5 | Financials | 9.22% |
Similar funds
EFT
GWL
CC
ABLA
SPCM
OPAM
ES
IMT
Rangeley Capital's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Rangeley Capital, which disclosed 82 positions worth $111M. Its ten largest holdings account for 51% of the portfolio.
Its largest position is Calumet Specialty Products: 534,600 shares worth $11.8M.
By sector, the portfolio is most concentrated in Energy at 20% of assets, followed by Healthcare and Materials.
- Rangeley Capital's largest Q4 2024 buy was Calumet Specialty Products: 534,600 shares worth $11.8M.
- Rangeley Capital's ten largest holdings make up 51% of its $111M portfolio in Q4 2024.
- Rangeley Capital disclosed 82 positions in Q4 2024, its first 13F filing on record.
Based on Rangeley Capital's 13F filing for Q4 2024, filed 12 Feb 2025.